Choi Junhee, Hwang Junsun, Kim Jin-Young, Choi Hongsoo
Department of Robotics Engineering, Daegu Gyeongbuk Institute of Science and Technology (DGIST), Daegu, 42988, Republic of Korea.
DGIST-ETH Microrobotics Research Center, Daegu Gyeongbuk Institute of Science and Technology (DGIST), Daegu, 42988, Republic of Korea.
Adv Healthc Mater. 2021 Mar;10(6):e2001596. doi: 10.1002/adhm.202001596. Epub 2020 Dec 16.
Therapeutic agents, such as drugs and cells, play an essential role in virtually every treatment of injury, illness, or disease. However, the conventional practices of drug delivery often result in undesirable side effects caused by drug overdose and off-target delivery. In the case of cell delivery, the survival rate of the transplanted cells is extremely low and difficulties with the administration route of cells remain a problem. Recently, magnetically actuated microrobots have started offering unique opportunities in targeted therapeutic delivery due to their tiny size and ability to access hard-to-reach lesions in a minimally invasive manner; considerable advances in this regard have been made over the past decade. Here, recent progress in magnetically actuated microrobots, developed for targeted drug/cell delivery, is presented, with a focus on their design features and mechanisms for controlled therapeutic release. Additionally, the practical challenges faced by the microrobots, and future research directions toward the swift bench-to-bedside translation of the microrobots are addressed.
治疗剂,如药物和细胞,在几乎所有的损伤、疾病或病症治疗中都起着至关重要的作用。然而,传统的药物递送方法常常会因药物过量和脱靶递送而导致不良副作用。在细胞递送方面,移植细胞的存活率极低,并且细胞给药途径的难题仍然存在。最近,磁驱动微型机器人因其微小的尺寸以及能够以微创方式进入难以到达的病灶的能力,开始在靶向治疗递送中提供独特的机遇;在过去十年里,这方面已经取得了相当大的进展。在此,介绍了为靶向药物/细胞递送而开发的磁驱动微型机器人的最新进展,重点关注其设计特点和控制治疗释放的机制。此外,还讨论了微型机器人面临的实际挑战以及微型机器人从实验室迅速转化到临床应用的未来研究方向。